ERT, a provider of Epro solutions, centralised ECG and Eclinical technology, will display its products and services at the 45th DIA Annual Meeting, 22-25 June 2009 in San Diego, California.
ERT will showcase its four new sub-brands at the event, including ERT Epro Solutions, ERT Cardiac Safety Solutions, ERT EDC Solutions and ERT Clinical Research Consulting Group.
ERT is also inviting delegates to attend a presentation from its partner, Healthcare Technology Systems (HTS), which will be held on 24 June from 3.30-5.00pm.
The presentation, entitled 'Addressing Suicidality in Clinical Trials' will be chaired by John H Greist, managing director of HTS, who will discuss FDA safety concerns and regulatory requirements regarding suicidality assessments and the Columbia Suicide Severity Rating Scale (C-SSRS) and Columbia Classification Algorithm of Suicide Assessment (C-CASA).
Delegates will be able to learn about computer-automated suicidality assessment options as well as about methods and techniques for follow-up with patients.
For further information or to register for the presentation, visit ERT's website.
The DIA Annual Meeting draws more than 5,000 industry professionals each year and more than 450 exhibiting companies from all over the world.
It also features more than 400 conference sessions, including speakers from key regulatory agencies, for example FDA and EMEA.
ERT is a leading provider of technology and services to the biopharmaceutical and medical-device industries.
